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ith Limited Resources: How to begin and How to Sustain
n Infection Control Program
. Wey
University of Sao Paulo, Sao Paulo, Brazil
Infection control (IC) efforts may encounter greater
bstacles in developing countries. However, progress
ppears to have been made composed of designated
nd trained doctors, nurses, and others. E-learning is an
mportant tool to bring health care professionals updated
nformation, especially where teaching resources are lim-
ted. It allows the exchange of experiences between
rofessionals, promotes simultaneous knowledge acquisi-
ion, and reaches some remote areas. Trained IC personnel
re a scarce resource and their job is to prevent and
ontrol infection; their time and expertise must not be dis-
roportionately utilized in counting infection only. Basic
urveillance is an essential component of IC Programs and
hould be tailored for each institution. The data should be
sed to identify preventable infections so that resources
re targeted in high priority areas requiring minimum
esources. In addition, surveillance data can be used to com-
are infection rates between healthcare facilities, convince
dministrators, clinical teams and health care professionals
o adopt recommended practices and help evaluate IC mea-
ures. For this last purpose one can easily ﬁnd Guidelines
ssued by international health institutions or professional
ocieties that indicate the basic requirements for an effec-
ive IC. The IC team should take into account to implement
easures that are more cost-effective, and use all effort
nd creativity to adopt tools that could improve compliance.
ositive Deviance method that is a social and behavioral
hange process based on the premise that in most organiza-
ions and communities there are people or groups of people
ho solve problems better than colleagues who have exactly
he same resources. Another important concern in develop-
ng countries is integrating epidemiology and microbiology.
espite its relevance, knowledge about the status of antibi-
tic resistance in the developing world remains on the whole
acking. Regional special laboratories could provide a good
mount of information about resistance and help in outbreak
ontrol.
oi:10.1016/j.ijid.2010.02.2225
0.004
he Future Hospital Epidemiologist’s Portfolio for Success
. Wenzel
VCU Medical Center, Richmond, VA, USA
It is understood that a successful Hospital Epidemiologist
ill need skills in clinical medicine, especially infectious dis-
ases, and in microbiology, epidemiology and informatics.
et that is only the beginning. Success builds on a platform
f skill sets that include Becoming Articulate and Persua-
ive and Becoming Inspiring. These skills can be taught. In
ddition a still more successful Hospital Epidemiologist will
eed to know more: How to Manage Something New; How to
anage Intimidation; and How to be Creative.
o
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The presentation will be accompanied by examples from
he experiences of the speaker as well as examples from
eaders in other ﬁelds.
oi:10.1016/j.ijid.2010.02.2226
acterial meningitis: Prevention and cure (Invited
resentation)
1.001
he Global Impact of Bacterial Meningitis
. Heath
St. George’s University of London, London, United Kingdom
Background: Bacterial meningitis is an important cause of
ortality and morbidity in neonates, infants, children and
dults worldwide.
Methods.
Review of published literature.
Results: Streptococcus pneumoniae, Haemophilus
nﬂuenzae type b, and Neisseria meningitidis are the most
mportant causes of acute bacterial meningitis worldwide.
number of other bacteria are capable of causing menin-
itis, often associated with speciﬁc population groups; for
xample, Streptococcus suis is a common cause of acute
acterial meningitis in southeast Asia but occurs rarely
lsewhere, Group B streptococcus is the leading cause
f neonatal meningitis in developed countries but less
requent in developing countries where Gram negative
acteria are more commonly implicated, while in HIV-
nfected patients, S pneumoniae is the commonest cause
f acute bacterial meningitis but meningitis caused by
ycobacterium tuberculosis and Cryptococcus neoformans
s also common. However, surveillance, especially in high
ortality developing countries usually under ascertains
acterial meningitis and sepsis due to the low sensitivity
f diagnostic tests and limited access to care. Furthermore
he long term sequelae of meningitis, a particular concern
ollowing neonatal meningitis, is poorly described. Finally,
ost reported estimates of meningitis incidence and
ase fatality ratios come from hospital-based surveillance
tudies only.
Conclusion: The global burden of bacterial meningitis is
ubstantial. Better standardisation and reporting of methods
nd limitations for surveillance studies are needed and more
esearch is required. Expanded use of established and new
accines could signiﬁcantly reduce both bacterial meningitis
nd overall mortality, especially in children.
oi:10.1016/j.ijid.2010.02.2227
1.002
athophysiology of bacterial meningitis
. Nau
Evangelisches Krankenhaus Göttingen-Weende & University
f Göttingen, Göttingen, Germany
Bacterial meningitis is characterized by the entry of
acteria into the cerebrospinal ﬂuid (CSF) and bacterial
rowth in this compartment leading to inﬂammation within
trac
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the CSF and the adjacent brain tissue. Long-term neu-
rological sequelae and death are caused jointly by the
following factors: (1) The systemic inﬂammatory response
of the host leads to leukocyte extravasation into the sub-
arachnoid space, an increased CSF outﬂow resistance, and
brain edema. The resulting elevated intracranial pressure
is an important cause of death in the acute phase and
of long-term sequelae. Systemic inﬂammation can also
cause vasculitis, cerebral venous thrombosis and secondary
ischemia. (2) Immune cells within the brain parenchyma,
in particular microglia, can be stimulated by proinﬂam-
matory bacterial compounds, which can directly lead to
neuronal injury. (3) Some bacterial compounds, e.g., pneu-
molysin, possess direct toxicity on neurons. Neuronal injury
is mediated by the release of reactive oxygen intermedi-
ates, proteases, cytokines and excitatory amino acids, the
activation of transcription factors, caspases, matrix metal-
loproteases and other proteases.
Rapid initiation of effective antibiotic therapy sterilizes
the CSF and reduces mortality of bacterial meningitis. In
industrialized countries, dexamethasone as an adjunctive
therapy to antibiotic treatment, improves outcome of bac-
terial meningitis, particularly of Streptococcus pneumoniae
meningitis. In experimental meningitis, dexamethasone as
an adjunct to antibiotic treatment causes an increase of
neuronal injury in the dentate gyrus of the hippocampal
formation, suggesting that corticosteroids might not be the
ideal adjunctive therapy. Several approaches that inter-
fere selectively with the mechanisms of neuronal injury,
including the use of non-bacteriolytic bactericidal protein
synthesis-inhibiting antibiotics, antioxidants and inhibitors
of transcription factors, matrix metalloproteinases, and cas-
pases, are effective in animal models. However, adequate
clinical studies are lacking. A recent randomized clinical
study points to a beneﬁcial effect of adjunctive oral glyc-
erol.
doi:10.1016/j.ijid.2010.02.2228
71.003
Vaccination Against Bacterial Meningitis
H. Peltola
Helsinki, Finland
Thanks to conjugate vaccines specially against
Haemophilus inﬂuenzae (Hib) and Streptococcus pneu-
moniae (Pnc), bacterial meningitis has become disease
whose global importance is no more realized in the afﬂuent
countries. However, more than 1 MI individuals a year,
proportionally more often children than adults, fall down;
one-third succumb, and one-third of survivors are left
with moderate-to-severe sequelae. In the world where the
meningitis problem is greatest, only a fraction of people
are vaccinated. The main (though not only) reason is the
too high cost of conjugates for those populations.
Years ago, inexpensive polysaccharide vaccines were
developed against Hib, Pnc, and Neisseria meningitidis
(Mnc). The Hib, polysaccharide is rightly gone, but all poten-
tial of polysaccharides against Pnc and Mnc has not been
used. The reasoning is that polysaccharides are not suf-
ﬁciently immunogenic in small children (in greatest risk).
o
o
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owever, convincing clinical efﬁcacy data are lacking to
rove this statement. It is unlikely that those data will ever
e produced, because people are too convinced of the supe-
iority of conjugates to support any major ﬁeld trial with a
nc or Mnc polysaccharide.
At present, variable conjugate vaccines are available
gainst Hib, 7-13 serotypes of Pnc, and up to 4 serogroups of
nc. Hib vaccination is indicated in all countries. So is also
nc conjugate, albeit its effect speciﬁcally against meningi-
is depends on local epidemiology (serotype distribution).
n case of Mnc meningitis, the main problem is the lack
f sufﬁciently good vaccine against serogroup B, the most
ommon group in many countries. Fortunately, encouraging
esults have been obtained recently regarding a new-type
f vaccine.
Group A Mnc is a special problem of Africa. Monovalent
onjugate has been used there, and luckily, its price is tol-
rable because of its manufacturing outside Big Farma. This
pproach would be welcome to cover other causative agents
f meningits as well.
oi:10.1016/j.ijid.2010.02.2229
1.004
ffective Adjuvant Therapies for Meningitis
. Singhi
Post-graduate Institute of Medical Education and Research,
handigarh, India
Objective: To review advances in adjuvant therapy of
acterial meningitis.
Data Sources: Work published within past 5 years
etrieved from personal knowledge and the U.S. National
ibrary of Medicine for terms: central nervous system infec-
ions, meningitisbacterial; therapy; corticosteroids; ﬂuids;
nti-inﬂammatory; glycerol, and pediatrics.
Study Selection, Data Extraction and Synthesis: Promis-
ng articles were reviewed and data used based on clinical
elevance and signiﬁcance.
Results: Corticosteroid therapy: Results from clinical
rials of adjuvant steroid therapy are conﬂicting. What
merges from meta-analysis is that in high-income countries
teroids reduce the risk of hearing loss in immunocompetent
atients with H. inﬂuenzae-b or pneumococcal meningitis;
here is no survival beneﬁt. In low-income countries utility
f corticosteroids is unclear.
Fluids: Evidence supports normal maintenance intra-
enous ﬂuids rather than restricted ﬂuids in the ﬁrst 48 hours
n settings; it reduces risk of spasticity and severe neurologic
equelae.
Oral glycerol therapy during ﬁrst 48 hours of treatment
an prevent severe neurologic sequelae. Within 6 hours of
dministration oral glycerol increased plasma osmolality by
%, which is known to reduce secretion of CSF and enhance
ovement of water back to plasma, and thus improve cere-
ral blood ﬂow.
Management of raised ICP is not easy because a variety
f mechanisms. Neuroimaging may be helpful in selection
f appropriate treatment. Cerebral perfusion pressure tar-
eted therapy to maintain CPP >50mmHg is likely to improve
he outcome.
